Evidence map›Paper›PMID 41917242›Full record

ArticleJournal of imaging informatics in medicine2026

3D deep learning model to predict the recurrence of stage IA invasive lung adenocarcinoma after sub-lobar resection: a multicenter retrospective cohort study.

Xin Fan, Chen Liang, Xue-Qin Ma, Yi-Bo Feng, Qian-Rui Fan, Da-Wei Wang, Tian-You Luo, Fa-Jin Lv, Qi Li

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of imaging informatics in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Xin FanDepartment of Radiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Chen LiangDepartment of Radiology, Second Affiliated Xinqiao Hospital of Army Medical University, No.83 Xinqiao Main Street, Shaping District, Chongqing, China.
Xue-Qin MaDepartment of Radiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Yi-Bo FengInstitute of Research, Infervision Medical Technology Co, Ltd, 25 F Building E, Yuanyang International Center, Chaoyang District, Beijing, China.
Qian-Rui FanInstitute of Research, Infervision Medical Technology Co, Ltd, 25 F Building E, Yuanyang International Center, Chaoyang District, Beijing, China.
Da-Wei WangInstitute of Research, Infervision Medical Technology Co, Ltd, 25 F Building E, Yuanyang International Center, Chaoyang District, Beijing, China.
Tian-You LuoDepartment of Radiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Fa-Jin LvDepartment of Radiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China. lvfj2020@sina.com.
Qi LiDepartment of Radiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China. 202770@hospital.cqmu.edu.cn.

Funding

the Chongqing medical scientific research project (Joint project of Chongqing Health Commission and Science and Technology Bureau) 2026MSXM021the Chongqing Municipal Science and Technology Commission (General Program) CSTB2025NSCQ-GPX1205
6 · The paper itself

Abstract

The purpose of this study was to investigate the efficacy of a three-dimensional (3D) deep learning (DL) model in predicting recurrence risk of stage IA invasive lung adenocarcinoma (ILADC) after sub-lobar resection (SLR). A total of 287 stage IA ILADC patients were assigned to training and internal validation sets (4:1), with an external test cohort of 112 patients from two institutions. Three clinical models, five 3D DL models and a combined clinic-radiological-DL model were developed. Model performance was compared to identify the best-performing one. Patients were stratified into high/low-risk groups using the optimal predictive probability threshold from the best model. Survival analysis was performed to compare prognosis between groups. Furthermore, the pathological-molecular characteristics of tumors were compared between high/low-risk groups. Among clinical models, SVM achieved the highest AUCs (training: 0.819, internal validation: 0.785, and external testing: 0.758). The 3D VGG-16 DL model outperformed others with AUCs of 0.921, 0.856, and 0.830, respectively. The combined model yielded AUCs of 0.932, 0.882, and 0.854, respectively. Both 3D VGG-16 and the combined model showed significantly higher sensitivity than the clinical model (all p < 0.05). High-risk patients classified by 3D VGG-16 model had shorter recurrence-free survival/overall survival (all p < 0.05) and higher prevalence of micropapillary/solid-predominant growth pattern, STAS, and mutations or fusions in KRAS and ALK (all p < 0.05). 3D VGG-16 effectively predicts post-SLR recurrence risk for stage IA ILADC, serving as a potential tool to guide surgical treatment decisions.

Indexed as

AdenocarcinomaComputed tomographyDeep learningLung cancerSub-lobar resection

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.